
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Broadly directed SARS-CoV-2-specific CD4+ T cell response includes frequently detected peptide specificities within the membrane and nucleoprotein in patients with acute and resolved COVID-19
Janna Heide, Sophia Schulte, Matin Kohsar, et al.
PLoS Pathogens (2021) Vol. 17, Iss. 9, pp. e1009842-e1009842
Open Access | Times Cited: 47
Janna Heide, Sophia Schulte, Matin Kohsar, et al.
PLoS Pathogens (2021) Vol. 17, Iss. 9, pp. e1009842-e1009842
Open Access | Times Cited: 47
Showing 1-25 of 47 citing articles:
Dynamics of spike-and nucleocapsid specific immunity during long-term follow-up and vaccination of SARS-CoV-2 convalescents
Nina Koerber, Alina Priller, Sarah Yazici, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 58
Nina Koerber, Alina Priller, Sarah Yazici, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 58
BNT162b2-induced memory T cells respond to the Omicron variant with preserved polyfunctionality
Min Kyung Jung, Seong Dong Jeong, Ji Yun Noh, et al.
Nature Microbiology (2022) Vol. 7, Iss. 6, pp. 909-917
Open Access | Times Cited: 55
Min Kyung Jung, Seong Dong Jeong, Ji Yun Noh, et al.
Nature Microbiology (2022) Vol. 7, Iss. 6, pp. 909-917
Open Access | Times Cited: 55
Human coronavirus OC43-elicited CD4+ T cells protect against SARS-CoV-2 in HLA transgenic mice
Rúbens Prince dos Santos Alves, Julia Timis, Robyn Miller, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 15
Rúbens Prince dos Santos Alves, Julia Timis, Robyn Miller, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 15
Humoral and Cellular Immune Response After Third and Fourth SARS-CoV-2 mRNA Vaccination in Liver Transplant Recipients
Aenne Harberts, Golda Schaub, Darius F. Ruether, et al.
Clinical Gastroenterology and Hepatology (2022) Vol. 20, Iss. 11, pp. 2558-2566.e5
Open Access | Times Cited: 37
Aenne Harberts, Golda Schaub, Darius F. Ruether, et al.
Clinical Gastroenterology and Hepatology (2022) Vol. 20, Iss. 11, pp. 2558-2566.e5
Open Access | Times Cited: 37
Longitudinal Assessment of SARS-CoV-2-Specific T Cell Cytokine-Producing Responses for 1 Year Reveals Persistence of Multicytokine Proliferative Responses, with Greater Immunity Associated with Disease Severity
Jonah Lin, Ryan Law, Chapin S. Korosec, et al.
Journal of Virology (2022) Vol. 96, Iss. 13
Open Access | Times Cited: 30
Jonah Lin, Ryan Law, Chapin S. Korosec, et al.
Journal of Virology (2022) Vol. 96, Iss. 13
Open Access | Times Cited: 30
Divergent adaptive immune responses define two types of long COVID
Jérôme Kervevan, Isabelle Staropoli, Dorsaf Slama, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 18
Jérôme Kervevan, Isabelle Staropoli, Dorsaf Slama, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 18
DNA Vaccines Expressing the Envelope and Membrane Proteins Provide Partial Protection Against SARS-CoV-2 in Mice
Jinni Chen, Yao Deng, Baoying Huang, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 28
Jinni Chen, Yao Deng, Baoying Huang, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 28
Deficiency of SARS-CoV-2 T-cell responses after vaccination in long-term allo-HSCT survivors translates into abated humoral immunity
Sigrun Einarsdottir, Anna Martner, J. Waldenström, et al.
Blood Advances (2022) Vol. 6, Iss. 9, pp. 2723-2730
Open Access | Times Cited: 22
Sigrun Einarsdottir, Anna Martner, J. Waldenström, et al.
Blood Advances (2022) Vol. 6, Iss. 9, pp. 2723-2730
Open Access | Times Cited: 22
Assessment of Immunogenic and Antigenic Properties of Recombinant Nucleocapsid Proteins of Five SARS-CoV-2 Variants in a Mouse Model
Alexandra Rak, N. Gorbunov, В. А. Костевич, et al.
Viruses (2023) Vol. 15, Iss. 1, pp. 230-230
Open Access | Times Cited: 12
Alexandra Rak, N. Gorbunov, В. А. Костевич, et al.
Viruses (2023) Vol. 15, Iss. 1, pp. 230-230
Open Access | Times Cited: 12
Development of Next Generation Vaccines against SARS-CoV-2 and Variants of Concern
Abdul Aziz Al-Fattah Bin Yahaya, Kanwal Khalid, Hui Xuan Lim, et al.
Viruses (2023) Vol. 15, Iss. 3, pp. 624-624
Open Access | Times Cited: 12
Abdul Aziz Al-Fattah Bin Yahaya, Kanwal Khalid, Hui Xuan Lim, et al.
Viruses (2023) Vol. 15, Iss. 3, pp. 624-624
Open Access | Times Cited: 12
SARS-CoV-2 epitope-specific T cells: Immunity response feature, TCR repertoire characteristics and cross-reactivity
Gang Yang, Junxiang Wang, Ping Sun, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 12
Gang Yang, Junxiang Wang, Ping Sun, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 12
Structural definition of HLA class II-presented SARS-CoV-2 epitopes reveals a mechanism to escape pre-existing CD4+ T cell immunity
Yuan Chen, Georgina H. Mason, David Oliver Scourfield, et al.
Cell Reports (2023) Vol. 42, Iss. 8, pp. 112827-112827
Open Access | Times Cited: 12
Yuan Chen, Georgina H. Mason, David Oliver Scourfield, et al.
Cell Reports (2023) Vol. 42, Iss. 8, pp. 112827-112827
Open Access | Times Cited: 12
The trend of phylogenetic and epitope variations of SARS-CoV-2 Omicron sub-lineages in Iran
Mehdi Shabani, Ahmad Nejati, Jila Yavarian, et al.
Frontiers in Microbiology (2025) Vol. 15
Open Access
Mehdi Shabani, Ahmad Nejati, Jila Yavarian, et al.
Frontiers in Microbiology (2025) Vol. 15
Open Access
Immunogenicity against wild-type and Omicron SARS-CoV-2 after a third dose of inactivated COVID-19 vaccine in healthy adolescents
Daniel Leung, Carolyn A. Cohen, Xiaofeng Mu, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 10
Daniel Leung, Carolyn A. Cohen, Xiaofeng Mu, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 10
Mixed lipopeptide-based mucosal vaccine candidate induces cross-variant immunity and protects against SARS-CoV-2 infection in hamsters
Raj S. Patel, Diana Duque, Jegarubee Bavananthasivam, et al.
ImmunoHorizons (2025) Vol. 9, Iss. 2
Open Access
Raj S. Patel, Diana Duque, Jegarubee Bavananthasivam, et al.
ImmunoHorizons (2025) Vol. 9, Iss. 2
Open Access
T cells in SARS-CoV-2 infection and vaccination
Arthur P. Young
Therapeutic Advances in Vaccines and Immunotherapy (2022) Vol. 10
Open Access | Times Cited: 16
Arthur P. Young
Therapeutic Advances in Vaccines and Immunotherapy (2022) Vol. 10
Open Access | Times Cited: 16
Tissue immunity to SARS‐CoV‐2: Role in protection and immunopathology*
Ksenia Rybkina, Julia Davis‐Porada, Donna L. Färber
Immunological Reviews (2022) Vol. 309, Iss. 1, pp. 25-39
Open Access | Times Cited: 15
Ksenia Rybkina, Julia Davis‐Porada, Donna L. Färber
Immunological Reviews (2022) Vol. 309, Iss. 1, pp. 25-39
Open Access | Times Cited: 15
T-Cell Epitope Mapping of SARS-CoV-2 Reveals Coordinated IFN-γ Production and Clonal Expansion of T Cells Facilitates Recovery from COVID-19
Xing Fan, Jin‐Wen Song, Wenjing Cao, et al.
Viruses (2024) Vol. 16, Iss. 7, pp. 1006-1006
Open Access | Times Cited: 3
Xing Fan, Jin‐Wen Song, Wenjing Cao, et al.
Viruses (2024) Vol. 16, Iss. 7, pp. 1006-1006
Open Access | Times Cited: 3
A systemic review of T-cell epitopes defined from the proteome of SARS-CoV-2
Xiaoxiao Jin, Xiaotao Liu, Chuanlai Shen
Virus Research (2022) Vol. 324, pp. 199024-199024
Open Access | Times Cited: 14
Xiaoxiao Jin, Xiaotao Liu, Chuanlai Shen
Virus Research (2022) Vol. 324, pp. 199024-199024
Open Access | Times Cited: 14
Mucosal immunization with lipopeptides derived from conserved regions of SARS-CoV-2 antigens induce robust cellular and cross-variant humoral immune responses in mice
Raj S. Patel, Babita Agrawal
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 7
Raj S. Patel, Babita Agrawal
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 7
High‐resolution analysis of individual spike peptide‐specific CD4 + T‐cell responses in vaccine recipients and COVID ‐19 patients
Hendrik Karsten, Leon Cords, Tim Westphal, et al.
Clinical & Translational Immunology (2022) Vol. 11, Iss. 8
Open Access | Times Cited: 12
Hendrik Karsten, Leon Cords, Tim Westphal, et al.
Clinical & Translational Immunology (2022) Vol. 11, Iss. 8
Open Access | Times Cited: 12
Bioinformatic elucidation of conserved epitopes to design a potential vaccine candidate against existing and emerging SARS-CoV-2 variants of concern
Amber Rastogi, Sakshi Gautam, Manoj Kumar
Heliyon (2024) Vol. 10, Iss. 15, pp. e35129-e35129
Open Access | Times Cited: 2
Amber Rastogi, Sakshi Gautam, Manoj Kumar
Heliyon (2024) Vol. 10, Iss. 15, pp. e35129-e35129
Open Access | Times Cited: 2
A universal MHCII technology platform to characterize antigen-specific CD4+ T cells
Rohit Vyasamneni, Victoria Kohler, Binisha Karki, et al.
Cell Reports Methods (2023) Vol. 3, Iss. 1, pp. 100388-100388
Open Access | Times Cited: 6
Rohit Vyasamneni, Victoria Kohler, Binisha Karki, et al.
Cell Reports Methods (2023) Vol. 3, Iss. 1, pp. 100388-100388
Open Access | Times Cited: 6
Evidence for broad cross-reactivity of the SARS-CoV-2 NSP12-directed CD4+ T-cell response with pre-primed responses directed against common cold coronaviruses
Tim Westphal, Maria Mader, Hendrik Karsten, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 6
Tim Westphal, Maria Mader, Hendrik Karsten, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 6
Heterologous immunity induced by 1st generation COVID-19 vaccines and its role in developing a pan-coronavirus vaccine
Raj S. Patel, Babita Agrawal
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 9
Raj S. Patel, Babita Agrawal
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 9